One afternoon in April 2022, in the city of Baltimore, Maryland, U.S., I found myself lying on the floor in front of a toilet. Researchers at the University of Maryland had recruited me and about 15 others to join this study to test a new vaccine that one day may hopefully prevent Shigellosis. We were given the experimental vaccine, and …
